Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Cancer Genomics & Proteomics
    • Anticancer Research
    • In Vivo

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Genomics & Proteomics
  • Other Publications
    • Cancer Genomics & Proteomics
    • Anticancer Research
    • In Vivo
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Cancer Genomics & Proteomics

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Visit iiar on Facebook
  • Follow us on Linkedin
Research Article

Screening for Epigenetically Masked Genes in Colorectal Cancer Using 5-Aza-2’-deoxycytidine, Microarray and Gene Expression Profile

Ahmed Khamas, Toshiaki Ishikawa, Kazuro Shimokawa, Kaoru Mogushi, Satoru Iida, Megumi Ishiguro, Hiroshi Mizushima, Hiroshi Tanaka, Hiroyuki Uetake and Kenichi Sugihara
Cancer Genomics & Proteomics March 2012, 9 (2) 67-75;
Ahmed Khamas
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Toshiaki Ishikawa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kazuro Shimokawa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kaoru Mogushi
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Satoru Iida
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Megumi Ishiguro
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hiroshi Mizushima
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hiroshi Tanaka
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hiroyuki Uetake
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kenichi Sugihara
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Figure 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1.

    Methylation specific polymerase chain reaction (MSP) analysis results. Methylation status of p14ARF, p16INK4A (A) and SCARA5 (D) in the five CRC cell lines before and after 5-aza-2’ deoxycytidine (5-aza-dC) treatment, showing promoter demethylation after treatment. Representative MSP results in 15 CRC cell lines (B) and 23 pairs of primary colorectal tumor (Tumor) and normal epithelium (Normal) (C). M and U denote the presence of PCR product using primers specific for methylated and unmethylated sequences, respectively. Fully methylated and unmethylated human genomic DNA (HCT15 cell line and genomic DNA from whole blood in (A)) were used as positive controls (+ve) for methylated and unmethylated DNA, respectively. Reactions that contained no template DNA were used as a negative control (–ve). The expected size of the amplicon in base pairs is indicated on the right side of the panels.

  • Figure 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 2.

    Outline of selection of candidate genes in CRC.

  • Figure 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 3.

    Heatmap showing expression of the 16 candidate genes in CRC based on microarray analysis. The panels show fold change in gene expression after 5-aza-dC treatment compared to mock-treated cells (left), and overexpression in normal epithelium in comparison to CRC tumor tissues (right). Rows represent individual genes and columns represent individual CRC cell lines (left), and normal and tumor tissue samples (right). In each panel, the fold change is depicted according to the color score shown at the bottom right. Genes selected for validation in this study are indicated by bold letters.

  • Figure 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 4.

    Boxplot showing markedly reduced expression of SCARA5 in CRC. SCARA5 mRNA expression in 14 CRC cell lines and 14 paired tissue samples determined by RTQ-PCR. β-Actin was used as a reference gene. CRC cell lines and tumor tissue samples had lower SCARA5 expression than normal epithelium (p<0.001 and p=0.001, respectively); there was also a significant decrease in expression in CRC cell lines compared to tumor tissues (p<0.001). P-values were calculated by Wilcoxon signed ranks test for paired samples or Mann-Whitney test for unpaired samples.

Tables

  • Figures
  • Table I.
  • Table II.
PreviousNext
Back to top

In this issue

Cancer Genomics - Proteomics: 9 (2)
Cancer Genomics & Proteomics
Vol. 9, Issue 2
March-April 2012
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Cancer Genomics & Proteomics.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Screening for Epigenetically Masked Genes in Colorectal Cancer Using 5-Aza-2’-deoxycytidine, Microarray and Gene Expression Profile
(Your Name) has sent you a message from Cancer Genomics & Proteomics
(Your Name) thought you would like to see the Cancer Genomics & Proteomics web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
2 + 4 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Screening for Epigenetically Masked Genes in Colorectal Cancer Using 5-Aza-2’-deoxycytidine, Microarray and Gene Expression Profile
Ahmed Khamas, Toshiaki Ishikawa, Kazuro Shimokawa, Kaoru Mogushi, Satoru Iida, Megumi Ishiguro, Hiroshi Mizushima, Hiroshi Tanaka, Hiroyuki Uetake, Kenichi Sugihara
Cancer Genomics & Proteomics Mar 2012, 9 (2) 67-75;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Screening for Epigenetically Masked Genes in Colorectal Cancer Using 5-Aza-2’-deoxycytidine, Microarray and Gene Expression Profile
Ahmed Khamas, Toshiaki Ishikawa, Kazuro Shimokawa, Kaoru Mogushi, Satoru Iida, Megumi Ishiguro, Hiroshi Mizushima, Hiroshi Tanaka, Hiroyuki Uetake, Kenichi Sugihara
Cancer Genomics & Proteomics Mar 2012, 9 (2) 67-75;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • An integrated computational and experimental study uncovers FUT9 as a metabolic driver of colorectal cancer
  • Google Scholar

Similar Articles

Cancer & Genome Proteomics

© 2021 Cancer Genomics & Proteomics

Powered by HighWire